Investigation of Volatile Metabolites in Sebum as Prodromal Indicators of Parkinson's Disease (2023)
Attributed to:
Molecular mapping of SARS-CoV2 and the host response with multiomics mass spectrometry to stratify disease outcomes
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2023.03.01.530578
Publication URI: http://dx.doi.org/10.1101/2023.03.01.530578
Type: Preprint